Managed Markets Perspectives 
May 8, 2015
  About Us
For 18 years, MedSpan Research has provided market research for healthcare manufacturers around the globe. We specialize in driving payer access and utilization of products in hospitals and post-acute care.
MedSpan Research
10 Executive Court
South Barrington, Illinois 60010
224.595.8571

 

  medspan wave

Every day, MedSpan Research investigates the nuances of payers, ACOs, IDNs and other agents of change in the healthcare delivery system to help our clients develop successful marketing strategies and initiatives. This newsletter shares those perspectives with you. 

 

 

Today we examine the growth of patient-centered medical homes and the effect they have on the US healthcare system.

We're Hiring!   
MedSpan Research is hiring a Field Services Associate.  The Associate is responsible for recruiting study respondents and managing our contact database.  This is an ideal position for an upcoming college graduate with good communication skills and some experience working with databases.  To apply, forward a resume to hr@MedSpanResearch.com.
 

Payers,  integra ted delivery networks (IDNs), accountable care organizations (ACOs) and states are increasingly sponsoring initiatives to develop patient-centered medical homes (PCMHs). 
 

Many initiatives utilize advanced compensation models that incorporate some form of capitation and/or pay-for-performance (P4P) bonus.  The shared-savings model also is catching on. 

 

From 2009 to 2013, the number of PCMH initiatives utilizing incentives has increased from 26 to 114. These initiatives have grown from 5 million to 21 million covered lives.

 

PCMHs are using a number of tools to earn the bonuses available under the incentives: open scheduling, expanded hours, better communication between patients, providers and staff, disease registries, online patient portals, information technology, and health information exchange among providers.  

 

MedSpan Research's Perspective

Healthcare companies that market drugs and other products for outpatient use for patients with chronic diseases should address these needs.  

For example, cl inical trials should be designed to deliver data that address the types of incentives under which PMCHs operate. Marketing messages should clearly convey how products will help PCMHs attain their incentive payments.  Value-added programs should support the inter-connectivity between primary care physicians and specialists and support improved cooperative decision-making between physicians and patients. 

 

 

Follow @MedSpanResearch

Follow us on Twitter
 

Access Insights

  Visit our blog 

Connect with MedSpan Research

View our profile on LinkedIn
 

___________________________________________________________________________________